Now, 75 years after the first presentations were made on the "sensational" effects of cortisone in the treatment of rheumatoid arthritis (RA), glucocorticoids (GCs) are still highly relevant and ...

Please provide your email address to receive an email when new articles are posted on . Half-dose conventional synthetic DMARDs are inferior to stable-dose regimens for preventing flares during a ...

Please provide your email address to receive an email when new articles are posted on . Tapering regimens were linked to significantly higher flare risk among patients in RA remission. The results ...

A new study suggests that the increased rates of overdose and mental health crisis observed during the first year after opioid dose tapering persist through the second year. Does dose reduction for ...

Manchester — Two-thirds of patients with rheumatoid arthritis (RA) who previously reached sustained disease control on tumour necrosis factor inhibitors (TNFi) maintain disease control for 1 year ...

Opioid-related policies and guidelines introduced in 2016 and 2017 meant to promote safer opioid prescribing were associated with temporary increases in abrupt opioid dose tapering, which can cause ...

In a study published Aug. 3 in JAMA, a team of UC Davis Health researchers examined the potential risks of opioid dose tapering. Their study found that patients on stable opioid therapy who had their ...

Tapering, in medical terms, means reducing your dosage of a medication gradually. It can occur over days to weeks. A doctor makes these dosage changes to wean you off a medication completely. Doctors ...

Aug. 3 (UPI) --Rapidly tapering patients off highly addictive opioid pain medications after long-term use at stable doses places them at increased risk for overdoses and mental health "crises," a ...

Researchers from the UC Davis Center for Healthcare Policy and Research examined the potential long-term risks of opioid dose tapering. They found that patients on stable but higher-dose opioid ...

Researchers from the UC Davis Center for Healthcare Policy and Research examined the potential long-term risks of opioid dose tapering. They found that patients on stable but higher-dose opioid ...